Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

GSK Investigational Site, New York

GSK Investigational Site, Berlin

GSK Investigational Site, Philadelphia

GSK Investigational Site, Newark

GSK Investigational Site, Milan

GSK Investigational Site, Toulouse

GSK Investigational Site, Montpellier

GSK Investigational Site, Immenhausen

GSK Investigational Site, Velbert

GSK Investigational Site, Meldola (FC)

GSK Investigational Site, Moers

GSK Investigational Site, Cologne

GSK Investigational Site, Rochester

GSK Investigational Site, Pisa

GSK Investigational Site, Heidelberg

GSK Investigational Site, Paris

GSK Investigational Site, Freiburg im Breisgau

GSK Investigational Site, Munich

GSK Investigational Site, Regensburg

GSK Investigational Site, Regensburg

GSK Investigational Site, Seattle

GSK Investigational Site, Everett

GSK Investigational Site, Moscow

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Kazan'

GSK Investigational Site, Chelyabinsk

GSK Investigational Site, Boston

GSK Investigational Site, Nice

GSK Investigational Site, Leipzig

GSK Investigational Site, Rome

GSK Investigational Site, Perugia

GSK Investigational Site, Chęciny

GSK Investigational Site, Lublin

GSK Investigational Site, Szczecin

GSK Investigational Site, Warsaw

GSK Investigational Site, Zakopane